AnnJi (7754.TWO)
- Previous Close
25.00 - Open
24.90 - Bid 24.90 x --
- Ask 25.25 x --
- Day's Range
24.90 - 25.25 - 52 Week Range
14.05 - 72.40 - Volume
65,607 - Avg. Volume
222,000 - Market Cap (intraday)
2.358B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-3.81 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AnnJi Pharmaceutical Co., Ltd. develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders. It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy, a neurodegenerative disease; AJ202 for androgenetic alopecia; AJ302, a histone deacetylase 6 inhibitor for the prevention and treatment of chemotherapy-induced peripheral neuropathy; and AJ303, an anti-fibrotic and anti-inflammatory compound for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. AnnJi Pharmaceutical Co., Ltd. was founded in 2014 and is based in Taipei, Taiwan.
www.ajpharm.comRecent News: 7754.TWO
View morePerformance Overview: 7754.TWO
Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare to: 7754.TWO
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: 7754.TWO
View moreValuation Measures
Market Cap
2.36B
Enterprise Value
1.71B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
24.32
Price/Book (mrq)
3.57
Enterprise Value/Revenue
17.75
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-20.37%
Return on Equity (ttm)
-44.61%
Revenue (ttm)
96.45M
Net Income Avi to Common (ttm)
-353.99M
Diluted EPS (ttm)
-3.81
Balance Sheet and Cash Flow
Total Cash (mrq)
706.01M
Total Debt/Equity (mrq)
8.36%
Levered Free Cash Flow (ttm)
-78.57M